These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17974725)

  • 21. Severely impaired health status at diagnosis of Pompe disease: a cross-sectional analysis to explore the potential utility of neonatal screening.
    Rigter T; Weinreich SS; van El CG; de Vries JM; van Gelder CM; Güngör D; Reuser AJ; Hagemans ML; Cornel MC; van der Ploeg AT
    Mol Genet Metab; 2012 Nov; 107(3):448-55. PubMed ID: 23040796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of Confirmed Newborn-Screened Patients With Pompe Disease Across the Disease Spectrum.
    Kronn DF; Day-Salvatore D; Hwu WL; Jones SA; Nakamura K; Okuyama T; Swoboda KJ; Kishnani PS;
    Pediatrics; 2017 Jul; 140(Suppl 1):S24-S45. PubMed ID: 29162675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Newborn screening for Pompe disease in Japan.
    Oda E; Tanaka T; Migita O; Kosuga M; Fukushi M; Okumiya T; Osawa M; Okuyama T
    Mol Genet Metab; 2011 Dec; 104(4):560-5. PubMed ID: 21963784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic efficacy of the fluorometric determination of enzyme activity for Pompe disease from dried blood specimens compared with lymphocytes-possibility for newborn screening.
    Lukacs Z; Nieves Cobos P; Mengel E; Hartung R; Beck M; Deschauer M; Keil A; Santer R
    J Inherit Metab Dis; 2010 Feb; 33(1):43-50. PubMed ID: 20033296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosing lysosomal storage disorders: Pompe disease.
    Bodamer OA; Dajnoki A
    Curr Protoc Hum Genet; 2012 Oct; Chapter 17():Unit17.11. PubMed ID: 23074069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease].
    Zhang HB; Zhang WM; Qiu JJ; Meng Y; Qiu ZQ
    Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):415-9. PubMed ID: 22931935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polysomnographic findings in infantile Pompe disease.
    Kansagra S; Austin S; DeArmey S; Kishnani PS; Kravitz RM
    Am J Med Genet A; 2013 Dec; 161A(12):3196-200. PubMed ID: 24123966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri.
    Hopkins PV; Campbell C; Klug T; Rogers S; Raburn-Miller J; Kiesling J
    J Pediatr; 2015 Jan; 166(1):172-7. PubMed ID: 25444528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newborn screening for pompe disease? a qualitative study exploring professional views.
    van El CG; Rigter T; Reuser AJ; van der Ploeg AT; Weinreich SS; Cornel MC
    BMC Pediatr; 2014 Aug; 14():203. PubMed ID: 25124044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group.
    ; Al Jasmi F; Al Jumah M; Alqarni F; Al-Sanna'a N; Al-Sharif F; Bohlega S; Cupler EJ; Fathalla W; Hamdan MA; Makhseed N; Nafissi S; Nilipour Y; Selim L; Shembesh N; Sunbul R; Tonekaboni SH
    BMC Neurol; 2015 Oct; 15():205. PubMed ID: 26471939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pompe disease: design, methodology, and early findings from the Pompe Registry.
    Byrne BJ; Kishnani PS; Case LE; Merlini L; Müller-Felber W; Prasad S; van der Ploeg A
    Mol Genet Metab; 2011 May; 103(1):1-11. PubMed ID: 21439876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Later-onset Pompe disease: early detection and early treatment initiation enabled by newborn screening.
    Chien YH; Lee NC; Huang HJ; Thurberg BL; Tsai FJ; Hwu WL
    J Pediatr; 2011 Jun; 158(6):1023-1027.e1. PubMed ID: 21232767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A retrospective study of six patients with late-onset Pompe disease].
    Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P
    Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Precision newborn screening for lysosomal disorders.
    Minter Baerg MM; Stoway SD; Hart J; Mott L; Peck DS; Nett SL; Eckerman JS; Lacey JM; Turgeon CT; Gavrilov D; Oglesbee D; Raymond K; Tortorelli S; Matern D; Mørkrid L; Rinaldo P
    Genet Med; 2018 Aug; 20(8):847-854. PubMed ID: 29120458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pompe disease: early diagnosis and early treatment make a difference.
    Chien YH; Hwu WL; Lee NC
    Pediatr Neonatol; 2013 Aug; 54(4):219-27. PubMed ID: 23632029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotype variations in early onset Pompe disease: diagnosis and treatment results with Myozyme.
    Pascual SI
    Adv Exp Med Biol; 2009; 652():39-46. PubMed ID: 20225018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late onset Pompe disease revealed by newborn screening.
    Levenson D
    Am J Med Genet A; 2011 May; 155A(5):fmviii-ix. PubMed ID: 21506259
    [No Abstract]   [Full Text] [Related]  

  • 38. The new era of Pompe disease: advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management.
    Kishnani PS; Beckemeyer AA; Mendelsohn NJ
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):1-7. PubMed ID: 22253049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The generation of induced pluripotent stem cells (iPSCs) from patients with infantile and late-onset types of Pompe disease and the effects of treatment with acid-α-glucosidase in Pompe's iPSCs.
    Higuchi T; Kawagoe S; Otsu M; Shimada Y; Kobayashi H; Hirayama R; Eto K; Ida H; Ohashi T; Nakauchi H; Eto Y
    Mol Genet Metab; 2014 May; 112(1):44-8. PubMed ID: 24642446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using Decision Analysis to Support Newborn Screening Policy Decisions: A Case Study for Pompe Disease.
    Prosser LA; Lam KK; Grosse SD; Casale M; Kemper AR
    MDM Policy Pract; 2018; 3(1):. PubMed ID: 30123835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.